Health ❯Healthcare

Diabetes

Diabetes Obesity Pharmaceuticals Market Competition Patient Care Chronic Diseases Clinical Trials Market Trends Medications Drug Development

Mounjaro Delivers Rapid Weight Loss as UK Health Officials Warn of Serious Risks

Regulators have linked more than 80 deaths to GLP-1 jabs, prompting the NHS to phase in prescriptions to curb unsupervised online sales.

Stories older than 24h

Skin barrier test could reshape diabetic foot ulcer closure standards

FDA Chief Criticizes Medical Establishment, Advocates Lifestyle Changes for Health

First Human Trial of Type 1 Diabetes Immunotherapy Underway in Australia

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

WeightWatchers Prepares for Bankruptcy as Weight Loss Drug Demand Surges

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Amgen Advances Weight-Loss Drug MariTide with Two Phase 3 Trials